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A number of cDNA clones encoding human ceruloplasmin were identified using two mixed oligonucleotide 
probes. One of these clones was shown by DNA sequence analysis to span from the complete N-terminal 
leader sequence to 114 amino acids short of the C-terminus. The leader sequence consists of 19 primarily 
hydrophobic amino acids. Northern blot analysis of RNA from human liver showed two species of cerulo- 
plasmin mRNA; a minor species of 3600 nucleotides and a major one of 4400 nucleotides. 
Ceruloplasmin Leader sequence 
1. INTRODUCTION 
Human CP is a blue glycoprotein of about 
132 kDa containing 6 copper atoms per molecule, 
7-8% carbohydrate and carries 90-95% of the 
blood plasma copper [1,2]. Takahashi et al. [3] 
have determined the complete primary structure of 
CP showing that it consists of a single polypeptide 
chain of 1046 amino acid residues. CP synthesis 
and/or secretion is altered by a number of 
physiological factors including inflammation [4], 
pregnancy [5] and development [6]. Experimental- 
ly plasma CP levels have been increased by ad- 
ministration of copper [7], estrogen [8], glucocor- 
ticoids [9] and turpentine [lo]. To investigate fur- 
ther the molecular mechanisms involved in the 
regulation of CP levels, analysis of mRNA levels 
and the CP gene is required. The purification of 
CP mRNA by immunoprecipitation of polysomes 
was reported by Gaitskhoki et al. [ll], who 
showed that this mRNA was translated in a wheat 
germ protein synthesis ystem to yield a protein of 
M, 84000. This result and other results from this 
Abbreviations: CP, ceruloplasmin, iron (II) : oxygen ox- 
idoreductase, EC 1.16.3.1; cDNA, DNA complementary 
to RNA; kb, kilobases; bp, base pairs 
m RNA size DNA sequence 
group led them to propose that CP was made as 
smaller molecular mass precursors and maturation 
of the protein involves ligation of the two precur- 
sor fragments [12,13]. All of this work, however, 
relied upon the specificity of the CP antibody. 
Here we report the isolation of a CP cDNA 
clone from a human liver cDNA library. Partial 
DNA sequence analysis confirmed the identity of 
the clone and showed that it spanned almost the 
entire coding region from the N-terminal leader se- 
quence to 114 amino acids short of the C-terminus, 
strongly suggesting that CP is synthesized as a 
single polypeptide. 
2. MATERIALS AND METHODS 
2.1. Screening of a human liver cDNA library 
Two mixed oligonucleotides predicted from the 
published amino acid sequence of human CP [3] 
were synthesized by L. Graf and N. Hoogenraad 
of LaTrobe University using an Applied 
Biosystems 381A DNA synthesizer. The 
oligonucleotides were cleaved from the resin, 
deprotected and without further purification, end- 
labelled with Td-polynucleotide kinase and 
[Y-~~P]ATP to a specific activity > lo8 cpm/pg 
[14]. The oligonucleotides were used to screen 
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replicate filters of a XgtlO library of cDNA from 
human liver RNA [ 151. The hybridizations were 
carried out in 6 x SSC (0.9 M NaCl, 0.09 M Na 
citrate, pH 8.0), 0.125% skim milk powder, 0.1% 
Triton X-100, initially at 50°C cooling to 20°C 
over 18 h. The filters were washed twice for 30 min 
with 6 x SSC at 20°C and twice for 15 min with 6 
x SSC at 37°C and exposed to Kodak XARS film 
for 18 h using an intensifying screen. Ten positive 
phages were picked, purified and the DNA was 
isolated [ 161. After digestion with EcoRI the insert 
sizes were analyzed by electrophoresis on 1% 
agarose gels. 
described by Wake and Mercer [18]. The RNA 
(10rg) was fractionated on a 1.8% (w/v) agarose 
gel containing formaldehyde [ 191, and transferred 
to nitrocellulose [20]. The CP mRNA was detected 
by hybridization with the 0.69 kb EcoRI fragment 
from XhCP.l (100 ng) which had been labelled by 
nick translation [20] to a specific activity of 
> lo* dpm/pg with [cu-32P]dCTP. The RNA ladder 
from Bethesda Research Laboratories was used to 
provide size markers. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of a human CP cDNA clone 
2.2. DNA sequence analysis 
The EcoRI fragments from the clones were 
subcloned into Ml 3 mp18 and the DNA sequence 
was determined using the dideoxy-chain termina- 
tion method [ 171. 
2.3. Northern blot analysis of RNA from human 
livers 
Total RNA was isolated from human livers as 
Using the complete amino acid sequence of 
human CP [3], we chose two amino acid regions as 
suitable for oligonucleotide probes for screening 
purposes. Fig.1 shows that the two sequences are 
close together (amino acids 667-672 and 690-695) 
thus maximizing the chance that positive clones 
would give a signal with both probes. In both cases 
a mixture of sixteen 17-mers were synthesized as 
described in section 2 and used without further 
A. 670 680 690 
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. . . PQTSLTLHMWPDTEGTFNVECLTTDHYTGGMKOKYT 
700 
Probe 2 
VNQ CR . 
B. Probe 1 Amino acid sequence 
Coding sequences 
Probe sequences 







Met Lys Gln Lys Tyr Thr 
AUG AA; CA; AA; Uh; AC 
TAC TT; GTE TT; AT; TG 
His Met Trp Pro Asp Thr 
U 
CA; AUG UGG CC: GA! AC 
G 







Fig. 1. Probes used for CP screen. (A) A portion of the amino acid sequence of CP from amino acid 660 to 700 is shown 
in single letter code. The amino acids used to deduce the sequences of the oligonucleotide probes are underlined. (B) 
Sequences of the mixed oligonucleotide probes used to screen for CP clones. The amino acid sequence and deduced 
coding sequences are shown in conventional orientation, the mixed probes are written 3’-5 ’ . 
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purification. A screen of 80000 plaques of a 
human cDNA library in XgtlO using the end- 
labelled probes yielded 42 clones that gave a 
positive signal with each probe mixture. Ten of 
these were isolated and one (AhCP. 1) was found to 
contain three EcoRI fragments of 1.74, 0.69 and 
0.43 kb, giving a total insert size of 2.86 kb. The 
other clones all had a common 0.69 kb band and 
four included the 0.43 kb band. 
3.2. Anatomy and partial DNA sequence analysis 
of CP cDNA 
To confirm the identity of the CP cDNA, DNA 
sequences from four regions of the clone including 
each EcoRI fragment were obtained and the 
predicted amino acid sequences compared with the 
human CP amino acid sequence [3]. Each EcoRI 
fragment yielded sequences that matched exactly 
with the published amino acid sequence (fig.2B), 
confirming the identity of the clone and showing 
that the cDNA clone had not resulted from a fu- 
sion of unrelated cDNA fragments during the clon- 
ing procedures. Fig.2A shows the regions of the 
protein encoded by the three EcoRI fragments. 
The 1.74 kb fragment extends beyond the N- 
terminus of the mature protein to include the com- 
plete leader sequence of CP (see below). The 
0.43 kb fragment terminates 114 amino acids from 
the C-terminus. The EcoRI sites are shown above 
the line and the amino acid sequences used to 
predict the primer structure are shown as Pl and 
P2 in fig.2A. The fact that all the clones ter- 
minated at EcoRI sites found in hhCP.l suggests 
that during the library construction, the EcoRI site 
methylation was incomplete, resulting in digestion 
of the cDNA during the linker removal. Unfor- 
tunately, none of the clones contained any 
fragments extending beyond the 3 ‘-EcoRI site so 
we were unable to obtain sequences from this 
region. 
3.3. Structure of the leader sequence of CP 
The predicted leader sequence of CP was ob- 
tained by sequencing both strands of the cDNA. 
This was achieved by subcloning the 140 nucleotide 
EcoRI-NcoI fragment from the 5’-end of the 
1.74 kb EcoRI fragment into Ml3 mp8 thus also 
allowing the sequence to be read back from the 
NcoI site. The leader peptide is a highly 
hydrophobic region of 19 amino acids (fig.2B, se- 
quence 1). It is likely that the methionine at - 19 
is the initiator since there is an in-frame termina- 
tion signal three codons upstream. In addition, the 
methionine is followed by a lysine, also 
characteristic of signal peptides [21]. The N- 
terminal lysine of the mature protein is preceded 
by an alanine, as is often found in this position 
ml. 
3.4. Characterization f human CP mRNA 
Liver RNA from 3 individuals was elec- 
trophoresed in formaldehyde agarose gels and 
transferred to nitrocellulose. As shown in fig.3, 
probing with nick translated 0.69 kb EcoRI frag- 
ment showed two mRNA species in each sample, 
the larger species was predominant and ran slightly 
ahead of the 28 S rRNA. The same two bands were 
observed with poly(A)+ RNA (fig.3B, lane 1) and 
no signal was detected with total RNA from brain 
stem (fig.3B, lane 2) showing that the upper band 
was not due to hybridization with 28 S rRNA. Us- 
ing RNA standards, we estimate the size of the two 
CP mRNAs to be approx. 4400 and 3600 
nucleotides, both significantly larger than that re- 
quired to encode the precursor CP (3195 
nucleotides). We are not sure why the signal given 
by the sample in lane 2 was less intense. From the 
ethidium bromide stained gel, all three samples 
were loaded equivalently. The mRNA in lane 2 was 
somewhat degraded as evidenced by the smearing 
at lower molecular masses, however, this does not 
seem sufficient to account for the differences. 
Both samples in lanes 1 and 3 were from accident 
victims, whereas the child in lane 2 died from 
methylene tetrahydrofolate reductase deficiency. 
The samples in lanes 1 and 2 were from 7-year-old 
males. The origin of sample 3 is not recorded ex- 
cept as accident victim. As yet we have no informa- 
tion about the effects of illness or age differences 
on CP mRNA levels. 
3.5. Conclusions 
The isolation of a CP clone that contains virtual- 
ly the entire coding region, and the detection of 
two mRNA species in humans, which are both 
large enough to encode CP, refutes the hypothesis 
of Puchkova et al. [12] and Prozorovski et al. [13] 
that CP is made as two smaller molecular mass 
proteins that are ligated to produce the mature 
molecule. It is possible that the antibody used by 
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A. 
E Nco E 
.1. 
NI-, . 
Psj fy T 
1 I I +c 
Ll 100 200 300 400 500 600 700 800 900 1000 
1.74 0.69 043 
* v v 
-19 -10 
1 Met Lys Ile Leu Ile Leu Gly Ile Phe Leu Phe Leu Cys 
ATT CCA GCC TGA GAA GAA An; Affi ATT TX ATA GTT GGT ATT TTT CTG TTT TTA 'ET 
1 10 
Ser Thr Pro Ala Trp Ala Lys Glu Lys His Tyr Tyr Ile Gly Ile Ile Glu Thr Thr 
AGT ACC CCA GCC TGG GCG AAA GAA AAG CAT TAT TAC ATT GGA ATT ATT GAA ACG ACT 
20 
Trp Asp Tyr Ala Ser Asp His Gly... 
TGG GAT TAT GCC TCT GAC CAT GGG.. . 
530 540 
2 . . . Ile Phe Thr Gly Leu Ile Gly Pro Met Lys Ile Cys Lys Lys Gly Ser Leu His Ala 
. . . ATA TTC ACT GGG CTT ATT GGG CCA ATG AAA ATA TGC AAG AAA GGA AGT TTA CAT GCA 
550 560 
Asn Gly Arg Gln Lys Asp Val Asp Lys Glu Phe Tyr Leu Phe Pro Thr Val Phe Asp 
AAT GGG AGA CAG AAA GAT GTA GAC AAG GAB TTC TAT TTG TTT CCT ACA GTA TTT GAT 
570 580 
Glu Asn Glu Ser Leu Leu Leu Glu Asp Asn Ile Arg Met.. . 
GAG AAT GAG AGT TTA CTC CTG GAA GAT AAT ATT AGA ATG. . . 
770 780 
3 . . . Tyr Arg Gln Tyr Thr Asp Ser Thr Phe Arg Val Pro Val Glu Arg Lys Ala Glu Glu 
. . . TP.T CGG CAG TAT ACT GAT AGC ACA TTC CGT GTT CCA GTG GAG AGA AAA GCT GAA GAA 
790 SO0 
Glu His Leu Gly Ile Leu Gly Pro Gln Leu His Ala Asp Val Gly Asp Lys Val Lys 
GAA CAT CTG GGA ATT CTA GGT CCA CAA CTT CAT GCA GAT GTT GGA GAC UA GTC AAA 
810 
Ile Ile Phe Lys Asn Met Ala Thr. . . 
ATT ATC TTT AAA AAC AX GCC ACA.. . 
900 910 
4 . . . Leu Phe Leu Val Phe Asp Glu Asn Glu Ser Trp Tyr Leu Asp Asp Asn Ile LyS Thr 
. . . CTG TTT CTA GTT TTT GAT GPG AAT GAA TCT TGG TAC TTA GAT GAC AAC ATC AAA ACA 
920 930 
Tyr Ser Asp His Pro Glu Lys Val Asn Lys Asp Asp Glu Glu Phe, . . 
TAC TCT GAT CAC CCC GAG AAA GTA UC AAA GAT GAT GAG GAA TTC.. . 
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Fig.2. (A) Anatomy of the ceruloplasmin clone. The solid line represents the CP protein sequence with the N-terminus 
(N) on the left and C-terminus on the right (C), the amino acid numbers with the N-terminus of the mature protein 
taken as 1 are shown beneath; the letter L below the line indicates the beginning of the leader sequence. Also below 
the line the regions spanned by the three EcoRI fragments (1.74,0.69 and 0.43 kb) of AhCP. 1. Above the line the letters 
E and Nco refer to the EcoRI and Ncol sites, respectively. P2 and Pl are the positions of the amino acid sequences 
used to generate the probes hown in fig.1. The lines labelled l-4 are the regions of DNA sequence shown in B. (B) 
Partial DNA sequence of the CP clone. The numbers l-4 refer to the regions indicated in (A). Amino acids are 
numbered from the mature N-terminus based on the sequence of Takahashi et al. [3]. In most cases the sequence is 
compiled from several separate readings of one strand, but the leader sequence (sequence 1) was read from both strands. 









Fig.3. Northern blot analysis of RNA from human liver. 
Total RNA (10 pg) or poly(A)+ RNA (400 ng) from 
three individuals was transferred to nitrocellulose from 
a 1.8% (w/v) agarose gel containing formaldehyde as 
described in the text and probed with the 0.69 kb EcoRI 
fragment from hhCP.l. (A) Autoradiography was for 
72 h. Lanes: 1, hepatic RNA from a 7-year-old accident 
victim; 2, hepatic RNA from a 7-year-old child who died 
from methylene tetrahydrofolate reductase deficiency; 
3, hepatic RNA from an accident victim. The position of 
the 18 S and 28 S ribosomal RNA species are indicated. 
(B) Autoradiography was for 18 h. Lanes: 1, hepatic 
poly(A)+ RNA from an accident victim; 2, total RNA 
from human brain stem. The sizes of the RNA standards 
in kb are indicated on the right. 
these workers was not monospecific for CP. Our 
cDNA clone will be useful for isolation of a rat 
cDNA clone which will allow us to study the 
response of CP mRNA to various agents such as 
copper and hormones. 
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